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Introduction
Immune mediated inflammatory diseases (IMIDs), such as
rheumatoid arthritis, psoriasis and Crohn’s disease are a
group of chronic conditions sharing common inflamma-
tory pathways. Inflammatory cytokine imbalance is central
in IMID pathophysiology suggesting a key role for CD4+
T cells in shaping the immune response via cytokine pro-
duction. Given the phenotypic and functional complexity
of the T-cell compartment, multiparameter flow cytometry
represents one of the best experimental tools to study
T cell biology.
Aim
The aim of our immuno-monitoring project is to develop
a flow cytometry-platform to define and validate immune
cell signatures in inflammatory diseases. In particular we
want to simultaneously analyze the frequency and func-
tional state (cytokine production, STAT protein phos-
phorylation) of T helper cell subsets relevant for IMIDs.
Patients and methods
Multicolour flow cytometry panels were developed for
the simultaneous detection of up to 10 parameters both
at surface and intracellular levels. PBMC are stimulated
with PMA/Ionomycin and then stained in 96 well plates
containing lyophilized reagents (lyoplates) to ensure con-
sistency and reproducibility between different primary
samples.
Cellular activation and signalling was assessed by
phosphoflow cytometry after ex vivo stimulation with
relevant proinflammatory cytokines.
Results
Three polychromatic (10 colours) flow cytometry panels
using the lyoplate platform have been developed to ana-
lyse the number, cytokine production (IFNg,I L 1 7 A ,I L 2 2
and IL10) and transcription factor expression (T-Bet,
RORC and FoxP3) of Th1, Th17 and Treg cells within
PBMC. A fourth panel has been designed to study T cell
activation by detecting constitutive and cytokine induced
phosphorylation of Stat1 and Stat3.
Conclusion
The multicolour flow cytometry platform we have opti-
mized is an excellent tool to characterize CD4+ T cell
subsets in both healthy controls and patients with
immune mediated inflammatory diseases.
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